Iodide

Iodide

SCHEMBL3820109

CN1C=CN(c2ccccc2)C1.I

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GSK3A P49840 1/20 0.34
GSK3B P49841 1/20 0.34
ATM Q13315 1/20 0.34
SIGMAR1 Q99720 2/20 0.33
DRD2 P14416 1/20 0.33
CHRNA7 P36544 2/20 0.32
MAPK1 P28482 2/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
CHRNB2 P17787 1/20 0.32
NFKB1 P19838 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRNA4 P43681 1/20 0.32
HSD17B10 Q99714 1/20 0.32
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL28360230 1.00 MAPT (0.36) MAPTNPSR1GSK3AGSK3BATM
SCHEMBL666883 0.98 MAPT (0.37) MAPTNPSR1GSK3AGSK3BATM
Hydrochloric Acid SCHEMBL384463 0.96 MAPT (0.36) MAPTNPSR1GSK3AGSK3BATM
SCHEMBL28696283 0.90 MAPT (0.33) MAPTNPSR1GSK3AGSK3BATM
SCHEMBL28331874 0.88 MAPT (0.33) MAPTNPSR1GSK3AGSK3BATM
Acetic Acid SCHEMBL27858063 0.88 POLB (0.37) MAPTGSK3AGSK3BMAPK1SMN1; SMN2
Phosphoric Acid SCHEMBL29033349 0.87 CA2 (0.33) MAPTNPSR1GSK3AGSK3BATM
Thiocyanic Acid SCHEMBL27709180 0.87 MAPT (0.32) MAPTNPSR1ATM
Iodide SCHEMBL30421956 0.85 ADRA2C (0.32)
Iodide SCHEMBL2530875 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12534485-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2026-01-27 US disclosed
US-20250368670-A1 TRANSITION METAL COMPLEX AND METHODS FOR ITS PREPARATION AND USE SHANGHAI UNITED IMAGING MICROELECTRONICS TECH CO LTD (CN) 2025-12-04 US disclosed
EP-4656647-A1 TRANSITION METAL COMPLEX AND METHODS FOR ITS PREPARATION AND USE Shanghai United Imaging Microelectronics Technology Co., Ltd. (CN) 2025-12-03 EP disclosed
US-20250207019-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2025-06-26 US disclosed
US-20250127030-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2025-04-17 US disclosed
US-12247150-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2025-03-11 US disclosed
US-12171138-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2024-12-17 US disclosed
CN-118684716-A Transition metal complex, preparation method and application thereof 上海联影微电子科技有限公司 2024-09-24 CN disclosed
US-20240284783-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-08-22 US disclosed
US-12018035-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2024-06-25 US disclosed
CN-102775447-A Stability OLED materials and devices with improved stability UNIVERSAL DISPLAY CORP 2012-11-14 CN disclosed
US-7902374-B2 Stability OLED materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2011-03-08 US disclosed
EP-1878053-B1 STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY UNIVERSAL DISPLAY CORP (US) 2009-08-26 EP disclosed
US-20090018330-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES BASF SE (DE) 2009-01-15 US disclosed
CN-101180304-A Stable OLED materials and devices with improved stability UNIVERSAL DISPLAY CORP (US) 2008-05-14 CN disclosed
WO-2008054584-A1 IMPROVED STABILITY OLED MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2008-05-08 WO disclosed
EP-1878053-A1 STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY Universal Display Corporation (US) 2008-01-16 EP disclosed
US-20070088167-A1 Stability OLED materials and devices UNIVERSAL DISPLAY CORPORATION 2007-04-19 US disclosed
WO-2006121811-A1 STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY UNIVERSAL DISPLAY CORPORATION (US) 2006-11-16 WO disclosed
US-20060251923-A1 Stability OLED materials and devices UNIVERSAL DISPLAY CORPORATION 2006-11-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018330-A1 PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES AP1M1, C1S, GPS1 MAPT 2625/4885NPSR1 2871/4885GSK3A 2235/4885
US-12534485-B2 Organic electroluminescent materials and devices LBR, GLRB, GLRA3 MAPT 4783/4885NPSR1 615/4885GSK3A 2825/4885
US-20250127030-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBP2, EML4, OSBP MAPT 463/4885NPSR1 4346/4885GSK3A 1820/4885
US-12171138-B2 Organic electroluminescent materials and devices OSBP2, EML4, OSBP MAPT 448/4885NPSR1 4348/4885GSK3A 1780/4885
US-20250207019-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OSBP, OCIAD1, OCIAD2 MAPT 1958/4885NPSR1 1791/4885GSK3A 3719/4885
US-12018035-B2 Organic electroluminescent materials and devices OXER1, ACSL3, ACSL1 MAPT 2801/4885NPSR1 461/4885GSK3A 2287/4885
US-12247150-B2 Organic electroluminescent materials and devices OSBP, OCIAD1, OCIAD2 MAPT 1958/4885NPSR1 1791/4885GSK3A 3719/4885
US-20240284783-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES LOXL4, RUVBL2, L1CAM MAPT 2781/4885NPSR1 2925/4885GSK3A 3193/4885
US-20250368670-A1 TRANSITION METAL COMPLEX AND METHODS FOR ITS PREPARATION AND USE AP2M1, AP1M1, AP3M1 MAPT 4400/4885NPSR1 2877/4885GSK3A 4812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.